These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8937249)

  • 81. Failure to cure Leishmania braziliensis guyanensis cutaneous leishmaniasis with oral ketoconazole.
    Dedet JP; Jamet P; Esterre P; Ghipponi PM; Genin C; Lalande G
    Trans R Soc Trop Med Hyg; 1986; 80(1):176. PubMed ID: 3726992
    [No Abstract]   [Full Text] [Related]  

  • 82. Ketoconazole in cutaneous leishmaniasis.
    Weinrauch L; Livshin R; el-On J
    Br J Dermatol; 1987 Nov; 117(5):666-8. PubMed ID: 3689689
    [No Abstract]   [Full Text] [Related]  

  • 83. Efficacy of ketoconazole in cutaneous leishmaniasis.
    Weinrauch L; Livshin R; Even-Paz Z; El-On J
    Arch Dermatol Res; 1983; 275(5):353-4. PubMed ID: 6318670
    [No Abstract]   [Full Text] [Related]  

  • 84. Leishmaniasis: recent advances in treatment.
    Singh S; Sundar S; Singh VP
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512-3. PubMed ID: 9308581
    [No Abstract]   [Full Text] [Related]  

  • 85. Ketoconazole in antimonial unresponsive cases of Kala-azar.
    Jha TK; Singh NK; Jha S
    J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
    [No Abstract]   [Full Text] [Related]  

  • 86. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combination therapy in Kala-azar.
    Singh NK; Jha TK; Singh IJ; Jha S
    J Assoc Physicians India; 1995 May; 43(5):319-20. PubMed ID: 9081958
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Oral miltefosine in the treatment of kala-azar.
    Mohan A; Seth S
    Natl Med J India; 2000; 13(4):202-3. PubMed ID: 11002688
    [No Abstract]   [Full Text] [Related]  

  • 89. Ketoconazole in the treatment of visceral leishmaniasis (kala-azar).
    Ahasan HA; Rafiqueuddin AK; Azhar MA; Chowdhury MA
    Trop Doct; 1996 Oct; 26(4):197-8. PubMed ID: 8937249
    [No Abstract]   [Full Text] [Related]  

  • 90. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diagnosis and management of Kala azar.
    Singh UK
    Indian Pediatr; 1999 Mar; 36(3):231-6. PubMed ID: 10713835
    [No Abstract]   [Full Text] [Related]  

  • 93. Leishmaniasis chemotherapy--challenges and opportunities.
    Croft SL; Olliaro P
    Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Treatment of visceral leishmaniasis in 2004.
    Murray HW
    Am J Trop Med Hyg; 2004 Dec; 71(6):787-94. PubMed ID: 15642973
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.